118 related articles for article (PubMed ID: 16856868)
1. NGF receptor TrkAd5: therapeutic agent and drug design target.
Dawbarn D; Fahey M; Watson J; Tyler S; Shoemark D; Sessions R; Zhang R; Brady L; Willis C; Allen SJ
Biochem Soc Trans; 2006 Aug; 34(Pt 4):587-90. PubMed ID: 16856868
[TBL] [Abstract][Full Text] [Related]
2. TrkAd5: A novel therapeutic agent for treatment of inflammatory pain and asthma.
Watson JJ; Fahey MS; van den Worm E; Engels F; Nijkamp FP; Stroemer P; McMahon S; Allen SJ; Dawbarn D
J Pharmacol Exp Ther; 2006 Mar; 316(3):1122-9. PubMed ID: 16284276
[TBL] [Abstract][Full Text] [Related]
3. Identification and structure of the nerve growth factor binding site on TrkA.
Robertson AG; Banfield MJ; Allen SJ; Dando JA; Mason GG; Tyler SJ; Bennett GS; Brain SD; Clarke AR; Naylor RL; Wilcock GK; Brady RL; Dawbarn D
Biochem Biophys Res Commun; 2001 Mar; 282(1):131-41. PubMed ID: 11263982
[TBL] [Abstract][Full Text] [Related]
4. Targeting nerve growth factor in pain: what is the therapeutic potential?
Watson JJ; Allen SJ; Dawbarn D
BioDrugs; 2008; 22(6):349-59. PubMed ID: 18998753
[TBL] [Abstract][Full Text] [Related]
5. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors.
Maliartchouk S; Feng Y; Ivanisevic L; Debeir T; Cuello AC; Burgess K; Saragovi HU
Mol Pharmacol; 2000 Feb; 57(2):385-91. PubMed ID: 10648649
[TBL] [Abstract][Full Text] [Related]
6. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.
Wehrman T; He X; Raab B; Dukipatti A; Blau H; Garcia KC
Neuron; 2007 Jan; 53(1):25-38. PubMed ID: 17196528
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase receptor type Z dephosphorylates TrkA receptors and attenuates NGF-dependent neurite outgrowth of PC12 cells.
Shintani T; Noda M
J Biochem; 2008 Aug; 144(2):259-66. PubMed ID: 18477627
[TBL] [Abstract][Full Text] [Related]
8. Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities.
Zaccaro MC; Lee HB; Pattarawarapan M; Xia Z; Caron A; L'Heureux PJ; Bengio Y; Burgess K; Saragovi HU
Chem Biol; 2005 Sep; 12(9):1015-28. PubMed ID: 16183026
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys.
Bonofiglio R; Antonucci MT; Papalia T; Romeo F; Capocasale G; Caroleo MC; Di Fausto V; Aloe L
J Nephrol; 2007; 20(2):186-95. PubMed ID: 17514623
[TBL] [Abstract][Full Text] [Related]
11. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain.
Ugolini G; Marinelli S; Covaceuszach S; Cattaneo A; Pavone F
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2985-90. PubMed ID: 17301229
[TBL] [Abstract][Full Text] [Related]
12. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
Raychaudhuri SP; Raychaudhuri SK
Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
[TBL] [Abstract][Full Text] [Related]
13. High affinity not in the vicinity?
Barker PA
Neuron; 2007 Jan; 53(1):1-4. PubMed ID: 17196523
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
15. ProNGF inhibits NGF-mediated TrkA activation in PC12 cells.
Sobottka B; Reinhardt D; Brockhaus M; Jacobsen H; Metzger F
J Neurochem; 2008 Dec; 107(5):1294-303. PubMed ID: 18796003
[TBL] [Abstract][Full Text] [Related]
16. SH2-B beta expression in alveolar macrophages in BAL fluid of asthmatic guinea pigs and its role in NGF-TrkA-mediated asthma.
Li L; Kong L; Fang X; Jiang C; Wang Y; Zhong Z; Sun Q; Gu G; Zheng D; Meng R; Kang J
Respirology; 2009 Jan; 14(1):60-8. PubMed ID: 19144050
[TBL] [Abstract][Full Text] [Related]
17. Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells.
Park JB; Lee CK; Koh JS; Lee JK; Park EY; Riew KD
Spine (Phila Pa 1976); 2007 Aug; 32(18):1969-73. PubMed ID: 17700442
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate.
Micera A; Lambiase A; Stampachiacchiere B; Bonini S; Bonini S; Levi-Schaffer F
Cytokine Growth Factor Rev; 2007; 18(3-4):245-56. PubMed ID: 17531524
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo.
Shi Z; Birman E; Saragovi HU
Dev Neurobiol; 2007 Jun; 67(7):884-94. PubMed ID: 17506493
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin3A regulates axon growth independently of growth cone repulsion via modulation of TrkA signaling.
Ben-Zvi A; Ben-Gigi L; Yagil Z; Lerman O; Behar O
Cell Signal; 2008 Mar; 20(3):467-79. PubMed ID: 18096366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
